Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...

A review in Biomolecules and Biomedicine sheds light on how microRNAs (miRNAs)—small regulatory RNA molecules—play a central ...

Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been ...

Special Report: Recce Pharmaceuticals has secured patent acceptance in China for its synthetic anti-infectives RECCE® 327 ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...